新版医保药品目录公布！自明年1月1日起执行

Core Insights - The National Healthcare Security Administration and the Ministry of Human Resources and Social Security have issued the updated National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalog, along with the Commercial Health Insurance Innovative Drug Catalog for 2025, which will take effect on January 1, 2026 [1] Group 1: National Medical Insurance Drug Catalog - The 2025 National Medical Insurance Drug Catalog successfully adds 114 new drugs, including 50 innovative drugs classified as Category I, achieving an overall success rate of 88%, which is a significant increase from 76% in 2024 [1] - The total number of drugs in the adjusted National Medical Insurance Drug Catalog has increased to 3,253, comprising 1,857 Western medicines and 1,396 traditional Chinese medicines [1] - The updated catalog notably enhances coverage for key areas such as oncology, chronic diseases, mental health, rare diseases, and pediatric medications [1] Group 2: Commercial Health Insurance Innovative Drug Catalog - The first version of the Commercial Health Insurance Innovative Drug Catalog includes 19 new drugs [1]